Moreover, it’s noteworthy that a majority of APL patients harboring the PLZF::RARα fusion initially manifest with non-specific symptoms that were identical to classical APL, including fever, pancytopenia, fatigue, bone pain, and so forth (Table 3). Here, ZBTB16 is linked to acute promyelocytic leukemia.